Drug policy, whether for legal or illegal substances, is a controversial field that encompasses many complex issues. Policies can have effects on a myriad of outcomes and stakeholders differ in the outcomes they consider and value, while relevant knowledge on policy effects is dispersed across multiple research disciplines making integrated judgements difficult. Experts on drug harms, addiction, criminology and drug policy were invited to a decision conference to develop a multi-criterion decision analysis (MCDA) model for appraising alternative regulatory regimes. Participants collectively defined regulatory regimes and identified outcome criteria reflecting ethical and normative concerns. For cannabis and alcohol separately, participants ...
Drug policy is multi-dimensional and complex. It is also undergoing dramatic shifts; away from prohi...
Background Proper assessment of the harms caused by the misuse of drugs can inform policy makers in ...
The impact of alternative drug policy objectives, specifically harm reduction/harm minimisation or p...
Drug policy, whether for legal or illegal substances, is a controversial field that encompasses many...
Background Drug policy, whether for legal or illegal substances, is a controversial field that encom...
Background Drug policy, whether for legal or illegal substances, is a controversial field that enco...
Background: Globally, non-medical heroin use is generating significant public health and social harm...
BACKGROUND: Globally, non-medical heroin use is generating significant public health and social harm...
Background: Ecstasy (3,4-methylenedioxymethamphetamine (MDMA)) has a relatively low harm and low dep...
Background: A number of jurisdictions are considering or implementing different options for cannabis...
Background:Ecstasy (3,4-methylenedioxymethamphetamine (MDMA)) has a relatively low harm and low depe...
The aim of this paper is to describe a new comprehensive approach to studying illicit drug policy - ...
Drug scheduling within the international system of drug control and national legislation has been re...
Cannabis, marijuana, pot, ganja - it goes by many names -- is by far the most widely used illegal su...
When analyzing the policy and decisions of policymakers we want to keep in mind the effectiveness, e...
Drug policy is multi-dimensional and complex. It is also undergoing dramatic shifts; away from prohi...
Background Proper assessment of the harms caused by the misuse of drugs can inform policy makers in ...
The impact of alternative drug policy objectives, specifically harm reduction/harm minimisation or p...
Drug policy, whether for legal or illegal substances, is a controversial field that encompasses many...
Background Drug policy, whether for legal or illegal substances, is a controversial field that encom...
Background Drug policy, whether for legal or illegal substances, is a controversial field that enco...
Background: Globally, non-medical heroin use is generating significant public health and social harm...
BACKGROUND: Globally, non-medical heroin use is generating significant public health and social harm...
Background: Ecstasy (3,4-methylenedioxymethamphetamine (MDMA)) has a relatively low harm and low dep...
Background: A number of jurisdictions are considering or implementing different options for cannabis...
Background:Ecstasy (3,4-methylenedioxymethamphetamine (MDMA)) has a relatively low harm and low depe...
The aim of this paper is to describe a new comprehensive approach to studying illicit drug policy - ...
Drug scheduling within the international system of drug control and national legislation has been re...
Cannabis, marijuana, pot, ganja - it goes by many names -- is by far the most widely used illegal su...
When analyzing the policy and decisions of policymakers we want to keep in mind the effectiveness, e...
Drug policy is multi-dimensional and complex. It is also undergoing dramatic shifts; away from prohi...
Background Proper assessment of the harms caused by the misuse of drugs can inform policy makers in ...
The impact of alternative drug policy objectives, specifically harm reduction/harm minimisation or p...